Perfect Medical Health Management Limited (HKG:1830)
Hong Kong · Delayed Price · Currency is HKD 1.570
-0.010 (-0.63%)
Aug 22, 2025, 4:08 PM HKT
HKG:1830 Revenue
In the fiscal year ending March 31, 2025, Perfect Medical Health Management had annual revenue of 1.13B HKD, down -19.05%. Perfect Medical Health Management had revenue of 507.59M in the half year ending March 31, 2025, a decrease of -29.60%.
Revenue
1.13B
Revenue Growth
-19.05%
P/S Ratio
1.75
Revenue / Employee
1.16M
Employees
971
Market Cap
1.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.13B | -265.48M | -19.05% |
| Mar 31, 2024 | 1.39B | 4.08M | 0.29% |
| Mar 31, 2023 | 1.39B | 39.29M | 2.91% |
| Mar 31, 2022 | 1.35B | 260.20M | 23.88% |
| Mar 31, 2021 | 1.09B | -151.18M | -12.18% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 35.81B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| JD Health International | 71.34B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 33.49B |
| WuXi Biologics | 21.98B |
| CSPC Pharmaceutical Group | 28.49B |